Woodmont Investment Counsel »

Akero Therapeutics shares owned by Woodmont Investment Counsel

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Woodmont Investment Counsel from 13F filings

Historical chart of Woodmont Investment Counsel investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Woodmont Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Woodmont Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-09-30 $335k 6.6k 50.58
2023-06-30 $309k 6.6k 46.69
2023-03-31 $272k 7.1k 38.26
2022-12-31 $415k 7.6k 54.80
2022-09-30 $328k 9.6k 34.10
2022-06-30 $115k 12k 9.49
2022-03-31 $144k 10k 14.23
2021-12-31 $203k 9.6k 21.10